Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
20,599,999
-
Share change
-
-65,448
-
Total reported value
-
$95,796,936
-
Price per share
-
$4.66
-
Number of holders
-
67
-
Value change
-
-$618,510
-
Number of buys
-
30
-
Number of sells
-
27
Institutional Holders of AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) as of Q1 2020
As of 31 Mar 2020,
AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,599,999 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Nantahala Capital Management, LLC, BlackRock Inc., BAKER BROS. ADVISORS LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Aisling Capital Management LP, VANGUARD GROUP INC, MARSHALL WACE, LLP, Rock Springs Capital Management LP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.